carmustine has been researched along with Foot Diseases in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Foot Diseases: Anatomical and functional disorders affecting the foot.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenot, M | 1 |
Maillard, H | 1 |
Sierra-Fortuny, S | 1 |
De Ybarlucea, LR | 1 |
Célérier, P | 1 |
Antonijevic, N | 1 |
Radosevic-Radojkovic, N | 1 |
Colovic, M | 1 |
Jovanovic, V | 1 |
Rolovic, Z | 1 |
2 other studies available for carmustine and Foot Diseases
Article | Year |
---|---|
[Syringotropic cutaneous T-cell lymphoma mimicking dermatomycosis].
Topics: Carmustine; Clobetasol; Dermatomycoses; Diagnostic Errors; Female; Foot Diseases; Humans; Middle Age | 2012 |
Multifocal plasmacytoma of hand and foot bones.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality | 1996 |